OverviewChartProfileKey statisticsFinancialsNews
Derivatives
TraderScreen

Alnylam Pharmaceuticals/  US02043Q1076  /

IEX
14/06/2024  21:59:50 Chg. +0.41 Volume Bid- Ask- High Low
160.41USD +0.25% 33,635
Turnover: 5.41 mill.		 -Bid Size: - -Ask Size: - 163.01 159.61
GlobeNewswire 14/05 Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting
GlobeNewswire 09/05 ProQR Announces First Quarter 2024 Operating and Financial Results
GlobeNewswire 02/05 Codexis Reports First Quarter 2024 Financial Results
GlobeNewswire 02/05 PDS Biotech Appoints Stephan Toutain as Chief Operating Officer
GlobeNewswire 02/05 Regeneron Reports First Quarter 2024 Financial and Operating Results
GlobeNewswire 23/04 ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held M...
GlobeNewswire 11/04 Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board
GlobeNewswire 01/04 Autolus Therapeutics Announces Changes to its Board of Directors
GlobeNewswire 15/03 American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...
GlobeNewswire 13/03 3Daughters Announces Three New Appointments to Board of Directors
GlobeNewswire 07/03 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmace...
GlobeNewswire 06/03 Zenas BioPharma Appoints Patricia Allen to its Board of Directors
GlobeNewswire 29/02 Kidney Month: 31 Day of Action to Equip and Empower People to Fight Kidney Disease
GlobeNewswire 28/02 Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
GlobeNewswire 28/02 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmace...
GlobeNewswire 20/02 Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board
GlobeNewswire 02/02 Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
GlobeNewswire 17/01 Mary Beth DeLena Joins PepGen as General Counsel and Secretary
GlobeNewswire 13/12/2023 Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ Platform
GlobeNewswire 11/12/2023 Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeuti...
GlobeNewswire 28/11/2023 Codexis to Host Virtual KOL Event on its ECO Synthesis™ Platform and the Future of RNAi Therapeutics...
GlobeNewswire 28/11/2023 Korro Bio Appoints Dr. Rachel Meyers to Board of Directors
GlobeNewswire 14/11/2023 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmace...
GlobeNewswire 09/11/2023 SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible S...
GlobeNewswire 08/11/2023 SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Alnylam Pharmaceuticals, Inc. of an I...